AAIS
RXDX

ABN AMRO Investment Solutions’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

ABN AMRO Investment Solutions’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,281
Closed -$245K – 427
2023
Q1 		$245K Buy
+2,281
New +$245K 0.01% 388